Evidence map›Paper›PMID 32773257›Full record

ReviewPhytomedicine : international journal of phytotherapy and phytopharmacology2021

Potential influence of Nagella sativa (Black cumin) in reinforcing immune system: A hope to decelerate the COVID-19 pandemic.

Muhammad Fakhar-E-Alam Kulyar, Rongrong Li, Khalid Mehmood, Muhammad Waqas, Kun Li, Jiakui Li

Open access · greenAbstract readReview
In one paragraph

Review in Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 88 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Effect ofF1000Research · 2021
    Trial
  4. Article
  5. Harnessing the Hepatoprotective and Nephroprotective Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  6. Identification of Black Cumin (Plants (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Nutrients · 2023
    Article
  11. Natural Products as a Potential Source of Promising Therapeutics for COVID-19 and Viral Diseases.Evidence-based complementary and alternative medicine : eCAM · 2023
    Review
  12. Review
  13. Magnetite-Based Nanostructured Coatings Functionalized withAntibiotics (Basel, Switzerland) · 2022
    Article
  14. Molecules (Basel, Switzerland) · 2022
    Review
  15. Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  16. Determination of Therapeutic and Safety Effects ofBioMed research international · 2022
    Article
  17. Effect ofFrontiers in veterinary science · 2022
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Muhammad Fakhar-E-Alam KulyarCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
Rongrong LiDepartment of Neurology, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, Jiangsu, China.
Khalid MehmoodFaculty of Veterinary and Animal Sciences, The Islamia University of Bahawalpur-63100, Pakistan.
Muhammad WaqasCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China; Faculty of Veterinary & Animal Sciences, University of the Poonch, Rawalakot, District Poonch 12350, Azad Jammu & Kashmir, Pakistan.
Kun LiCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China. Electronic address: lik2014@sina.com.
Jiakui LiCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China. Electronic address: lijk210@sina.com.
Huazhong Agricultural University · CNIslamia University of Bahawalpur · PKNanjing General Hospital of Nanjing Military Command · CNUniversity of Azad Jammu and Kashmir · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The world is witnessing a difficult time. The race of developing a new coronavirus (COVID-19) vaccine is becoming more urgent. Many preliminary studies on the pathophysiology of COVID-19 patients have provided some clues to treat this pandemic. However, no suitable treatment has found yet. Various symptoms of patients infected with COVID-19 indicated the importance of immune regulation in the human body. Severe cases admitted to the intensive care unit showed high level of pro-inflammatory cytokines which enhanced the disease severity. Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients is another critical factor of disease severity and mortality. So, Immune modulation is the only way of regulating immune system. Nigella sativa has been used for medicinal purposes for centuries. The components of this plant are known for its intense immune-regulatory, anti-inflammatory, and antioxidant benefits in obstructive respiratory disorders. A molecular docking study also gave evidences that N. sativa decelerates COVID-19 and might give the same or better results than the FDA approved drugs. The aim of this review was to investigate the possible immune-regulatory effects of N. sativa on COVID-19 pandemic. Our review found N. sativa's Thymoquinone, Nigellidine, and α-hederin can be a potential influencer in reinforcing the immune response on molecular grounds.

Indexed as

COVID-19 Drug TreatmentAnimalsAnti-Inflammatory AgentsAntioxidantsBenzoquinonesDrug Evaluation, PreclinicalHumansImmune SystemMolecular Docking SimulationNigella sativaOleanolic AcidPandemicsPlant ExtractsSARS-CoV-2Anti-Inflammatory AgentsAntioxidantsBenzoquinonesOleanolic AcidPlant ExtractsthymoquinoneBlack seedCoronavirusCovid-19ImmunomodulationNagella sativaNigellidineThymoquinoneα-hederin

Identifiers

PMID32773257
PMCPMC7347483
OpenAlexW3042145765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.